Advances and challenges in studying noncoding RNA regulation of drug metabolism and development of RNA therapeutics

Baitang Ning, Dianke Yu, Aiming Yu

Research output: Contribution to journalReview article

Abstract

Accumulating evidence has demonstrated that genome-derived noncoding RNAs (ncRNAs) play important roles in modulating inter-individual variations observed in drug metabolism and disposition by controlling the expression of genes coding drug metabolizing enzymes and transporters (DMETs) and relevant nuclear receptors (NRs). With the understanding of novel ncRNA regulatory mechanisms and significance in the control of disease initiation and progression, RNA-based therapies are under active investigation that may expand the druggable targets from conventional proteins to RNAs and the genome for the treatment of human diseases. Herein we provide an overview of research strategies, approaches and their limitations in biochemical and pharmacological studies pertaining to ncRNA functions in the regulation of drug and nutrient metabolism and disposition, and discussion on the promise and challenges in developing RNA therapeutics.

Original languageEnglish (US)
Article number113638
JournalBiochemical Pharmacology
Volume169
DOIs
StatePublished - Nov 1 2019

Fingerprint

Untranslated RNA
Drug and Narcotic Control
Metabolism
Genes
RNA
Pharmaceutical Preparations
Human Genome
Cytoplasmic and Nuclear Receptors
Nutrients
Disease Progression
Therapeutics
Genome
Pharmacology
Gene Expression
Food
Enzymes
Research
Proteins

Keywords

  • Bioengineered RNA
  • Drug development
  • Drug metabolizing enzymes and transporters
  • Noncoding RNA
  • Pharmacoepigenetics
  • RNA therapeutics

ASJC Scopus subject areas

  • Biochemistry
  • Pharmacology

Cite this

Advances and challenges in studying noncoding RNA regulation of drug metabolism and development of RNA therapeutics. / Ning, Baitang; Yu, Dianke; Yu, Aiming.

In: Biochemical Pharmacology, Vol. 169, 113638, 01.11.2019.

Research output: Contribution to journalReview article

@article{2ae1f4547fa7426ca98475450aa6eb70,
title = "Advances and challenges in studying noncoding RNA regulation of drug metabolism and development of RNA therapeutics",
abstract = "Accumulating evidence has demonstrated that genome-derived noncoding RNAs (ncRNAs) play important roles in modulating inter-individual variations observed in drug metabolism and disposition by controlling the expression of genes coding drug metabolizing enzymes and transporters (DMETs) and relevant nuclear receptors (NRs). With the understanding of novel ncRNA regulatory mechanisms and significance in the control of disease initiation and progression, RNA-based therapies are under active investigation that may expand the druggable targets from conventional proteins to RNAs and the genome for the treatment of human diseases. Herein we provide an overview of research strategies, approaches and their limitations in biochemical and pharmacological studies pertaining to ncRNA functions in the regulation of drug and nutrient metabolism and disposition, and discussion on the promise and challenges in developing RNA therapeutics.",
keywords = "Bioengineered RNA, Drug development, Drug metabolizing enzymes and transporters, Noncoding RNA, Pharmacoepigenetics, RNA therapeutics",
author = "Baitang Ning and Dianke Yu and Aiming Yu",
year = "2019",
month = "11",
day = "1",
doi = "10.1016/j.bcp.2019.113638",
language = "English (US)",
volume = "169",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Advances and challenges in studying noncoding RNA regulation of drug metabolism and development of RNA therapeutics

AU - Ning, Baitang

AU - Yu, Dianke

AU - Yu, Aiming

PY - 2019/11/1

Y1 - 2019/11/1

N2 - Accumulating evidence has demonstrated that genome-derived noncoding RNAs (ncRNAs) play important roles in modulating inter-individual variations observed in drug metabolism and disposition by controlling the expression of genes coding drug metabolizing enzymes and transporters (DMETs) and relevant nuclear receptors (NRs). With the understanding of novel ncRNA regulatory mechanisms and significance in the control of disease initiation and progression, RNA-based therapies are under active investigation that may expand the druggable targets from conventional proteins to RNAs and the genome for the treatment of human diseases. Herein we provide an overview of research strategies, approaches and their limitations in biochemical and pharmacological studies pertaining to ncRNA functions in the regulation of drug and nutrient metabolism and disposition, and discussion on the promise and challenges in developing RNA therapeutics.

AB - Accumulating evidence has demonstrated that genome-derived noncoding RNAs (ncRNAs) play important roles in modulating inter-individual variations observed in drug metabolism and disposition by controlling the expression of genes coding drug metabolizing enzymes and transporters (DMETs) and relevant nuclear receptors (NRs). With the understanding of novel ncRNA regulatory mechanisms and significance in the control of disease initiation and progression, RNA-based therapies are under active investigation that may expand the druggable targets from conventional proteins to RNAs and the genome for the treatment of human diseases. Herein we provide an overview of research strategies, approaches and their limitations in biochemical and pharmacological studies pertaining to ncRNA functions in the regulation of drug and nutrient metabolism and disposition, and discussion on the promise and challenges in developing RNA therapeutics.

KW - Bioengineered RNA

KW - Drug development

KW - Drug metabolizing enzymes and transporters

KW - Noncoding RNA

KW - Pharmacoepigenetics

KW - RNA therapeutics

UR - http://www.scopus.com/inward/record.url?scp=85072243859&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072243859&partnerID=8YFLogxK

U2 - 10.1016/j.bcp.2019.113638

DO - 10.1016/j.bcp.2019.113638

M3 - Review article

VL - 169

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

M1 - 113638

ER -